FDA draft guidance offers clarity for mobile medical apps
ACT executive director Morgan Reed issued the following statement today in response to the FDA’s draft guidance that would exempt many low risk medical apps and devices from FDA review: Today's draft guidance continues the FDA's strong push towards innovation-friendly policies. This clarification will help provide a clearer path for [...]